112 results
S-8
CLSD
Clearside Biomedical Inc
10 May 24
Registration of securities for employees
4:31pm
and Restricted Stock Unit Award Agreement under 2016 Equity Incentive Plan.
Opinion of Cooley LLP.
Consent of Ernst & Young LLP, independent registered
S-8
EX-23.1
CLSD
Clearside Biomedical Inc
10 May 24
Registration of securities for employees
4:31pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement
DEFA14A
CLSD
Clearside Biomedical Inc
26 Apr 24
Additional proxy soliciting materials
4:34pm
of the Company’s named executive officers, as disclosed in the proxy statement. 3. Ratification of the selection of Ernst & Young LLP as independent auditors
8-K
EX-10.2
1vn9bia bxy4j7x
8 Feb 24
Clearside Biomedical Announces Pricing of $15 Million Registered
5:05pm
8-K
EX-10.1
khidvnkzo a8w
8 Feb 24
Clearside Biomedical Announces Pricing of $15 Million Registered
5:05pm
8-K
EX-4.1
sc7rr
8 Feb 24
Clearside Biomedical Announces Pricing of $15 Million Registered
5:05pm
424B5
mwlg6kxsz5q6z6e2bq
8 Feb 24
Prospectus supplement for primary offering
4:52pm
8-K
xhlplz9j9 muz7uk9
22 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
EX-10.1
8z78hk9izpspgp6iauin
12 May 23
Entry into a Material Definitive Agreement
4:11pm
S-8
ajcxktz4dz9flsv
12 May 23
Registration of securities for employees
4:06pm
S-8
EX-23.1
b0t8n387h3hi
12 May 23
Registration of securities for employees
4:06pm
DEFA14A
mrj08pa
28 Apr 23
Additional proxy soliciting materials
8:42am